Navigation Links
CADCA and Leading Makers of OTC Medicines Call Communities to Action During National Medicine Abuse Awareness Month
Date:10/20/2011

WASHINGTON, Oct. 20, 2011 /PRNewswire-USNewswire/ -- Community Anti-Drug Coalitions of America (CADCA), the nation's leading substance abuse prevention organization representing over 5,000 community anti-drug coalitions across the country, and the Consumer Healthcare Products Association (CHPA), which represents the leading makers of over-the-counter (OTC) medicines, have joined forces to honor their annual National Medicine Abuse Awareness Month campaign to raise awareness of the dangers of youth prescription and OTC medicine abuse.

The U.S. Senate unanimously passed a resolution last month that named October as National Medicine Abuse Awareness Month. The joint CADCA and CHPA campaign features a coordinated and concentrated effort to educate parents and youth of the potential dangers associated with prescription and OTC medicine abuse.

"As we work toward curbing teen cough medicine abuse, education and community engagement continue to be our most valuable tools," said CHPA President and CEO Scott M. Melville. "National Medicine Abuse Awareness Month offers us the opportunity to provide additional resources to communities interested in raising awareness among parents and teens about the dangers of abusing cough medicine. Additionally, the leading makers of OTC cough medicines and our partners realize that as we tackle this issue head-on our efforts would be bolstered with federal legislative initiatives that would give parents further tools to address this type of abuse."

These initiatives include a federal ban on sales of OTC cough medicines to teens under the age of 18 and a federal restriction against the sale of the raw, unfinished form of dextromethorphan to anyone other than an entity registered by the U.S. Food and Drug Administration.

The Office of National Drug Control Policy reports that medicine abuse is our nation's fastest-growing drug problem. According to the National Survey on Drug Use and Health, in 2010, 2.4 milli
'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:7/10/2014)... 2014 Parker Waichman LLP, a ... of victims injured by defective medical devices, reports ... allegations that the woman’s hidden, aggressive leiomyosarcoma was ... used during a routine laparoscopic supracervical hysterectomy procedure. ... Medical Instruments Corporation over its Wolf Power Morcellator ...
(Date:7/10/2014)... record becomes widespread across the United States, due in ... the quantity of clinical data that will become available ... Additionally, experts in healthcare have become increasingly focused ... for the purpose of gleaning insights that have the ... a process that is known as big data. ...
(Date:7/10/2014)... with dyslexia are more likely to report that they ... who don,t have the learning disorder, according to a ... 10 percent of people, causes problems with reading and ... this condition said they suffered physical abuse during their ... "Even after accounting for age, race, sex and ...
(Date:7/10/2014)... July 10, 2014 (HealthDay News) -- Men who have ... prostate cancer, a new study suggests. But the ... urologists not involved with the study said more research ... truly accurate. For the study, Harvard researchers analyzed ... followed for 24 years, starting in 1986. During that ...
(Date:7/10/2014)... 10, 2014In response to today,s announcement that the "Mississippi ... has now been found to have detectable levels of ... expresses disappointment in this setback but remains hopeful that ... to remain undetectable for more than two years will ... and ultimately develop a cure. , "Although we ...
Breaking Medicine News(10 mins):Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2
... donations is spiraling for older couples wanting to start ... ... shifts in parenting,trends have fertility experts at Reproductive Endocrinology Associates of,Charlotte (REACH) ... 2008 -- including new outreach through the Internet --,in efforts to stem ...
... Patent Expands Geographic Coverage, IRVING, ... (OTC Bulletin Board: CARN) today announced ... patent application No. 200600484, titled,"Delivery of ... Anionic,Polysaccharides," relating to the Company,s proprietary ...
... Professor of Epidemiology and Associate Dean for Health Promotion ... of Medicine, and Virginia A. Stallings, MD, PhD, the ... Penn and Professor of Pediatrics at The Childrens Hospital ... a special public session, Understanding Obesity and Childhood at ...
... Nationally in, March 2008 Tells the Story of Six ... Mountain in the Himalayas with Blind Climber ... Entertainment and Junior,Blind of America announced today that from ... (opening March,2008) will travel to the United States for ...
... the Way to Educating Children With Food,Allergies, FAIRFAX, ... (FAAN) is proud to announce the release of two ... allergies.,Alexander, the Elephant Who Couldn,t Eat Peanuts ... Goes ... ... Gets a Babysitter help,children cope with their own ...
... Progress in Women,s Cancer, Theme, Spotlights Four ... Cancers, CHICAGO, Feb. 11 The Society ... Meeting on Women,s Cancer March,9-12 at the Tampa ... will feature more than 350 scientific presentations,lectures, workshops, ...
Cached Medicine News:Health News:Charlotte IVF Experts Issue Urgent Call for Egg Donors, Eye New Recruiting Tools 2Health News:Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office 2Health News:Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office 3Health News:Blind Tibetan Teenagers Featured in Award-Winning Film, 'Blindsight,' Unite with Students from Junior Blind of America to Share Life Experiences 2Health News:Blind Tibetan Teenagers Featured in Award-Winning Film, 'Blindsight,' Unite with Students from Junior Blind of America to Share Life Experiences 3Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 2Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 3Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 2Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 3
... Every Bard BrachyStar® Needle is designed ... an efficient and clinically effective brachytherapy procedure. ... featuring ultra-sharp tips and polished surfaces for ... of needle configurations and sizes assures an ...
... The BrachySource iodine-125 implant is a combination ... remarkable visibility that makes BrachySource I-125 implant ... You can be confident that every BrachySource ... seed management services which is required by ...
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
... Used for temporary internal drainage from the ... of a stricture. The segment with no ... lumen while preventing ingrowth of the ureteral ... peel-open packages. Intended for one-time use. CAUTION: ...
Medicine Products: